100 - Nursing Role in the Use of Longer-Acting Erythropoietin Agents

Contact hours available until 4/22/17.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:
• Denise Murcek – Employee, Fresenius Medical Care
• Dawn Koonkongsatian – Employee, Fresenius Medical Care
• Melissa Nesmith-Vester – Employee, Aegerion
• Elizabeth St. John - Employee, Fresenius Medical Care
• Kyra Trappett – Employee, DaVita

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.

Objectives:

• Relate desired patient outcomes in ESRD patients to the use of longer-acting erythropoiesis-stimulating agents (ESAs) to manage hemoglobin variability.
• Discuss the need for effective nursing knowledge and skills to participate in the care of patients receiving longer acting ESAs.
• Analyze the potential impact of effective nursing assessment and interventions on unit and patient factors that are known to impact the implementation of longer-acting ESAs.